Mission: Research for treatment of sanfilippo syndrome
Results: August 2019- the first FDA approved trial to treat multiple subtypes of Sanfilippo in broad range of ages . Team Sanfilippo has funded in collaboration with Seelos Therapeutics to execute this trial ! https://www. globenewswire. com/news-release/2019/08/22/1905441/0/en/Seelos-Therapeutics-Announces-FDA-Acceptance-of-IND-Application-for-SLS-005-for-Mucopolysaccharidosis-Type-III-Sanfilippo-Syndrome. html#. XV9Ypm-ea9Y. facebook
Geographic areas served: World wide based in USA
Programs: Research for treatment for sanfilippo syndrome, both older kids and younger with hopes of a cure one day !